Perinatal characteristics and early childhood follow up after ex-utero intrapartum treatment for head and neck teratomas by prenatal diagnosis.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
03 2021
Historique:
revised: 09 11 2020
received: 11 05 2020
accepted: 14 12 2020
pubmed: 3 1 2021
medline: 15 12 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

Ex utero intrapartum treatment (EXIT) is utilized for safe delivery when a baby has a compromised airway. The purpose of this retrospective study was to examine the indications and outcomes of 11 children presenting with airway occluding oropharyngeal and cervical teratomas. Study of all children with an airway occluding teratoma delivered via EXIT (2001-2018) in our unit. Primary outcomes included survival and tracheostomy at discharge. Data are reported using descriptive statistics as median (range) and rate (%). We performed 45 EXIT procedure performed between January 2001 and April 2018. Of these, eleven were for cervical and/or upper airway teratoma. Ten (91%) cases had associated polyhydramnios, two (18%) developed nonimmune hydrops, and eight (72%) delivered preterm. Six (45.5%) were performed as an emergency. Estimated blood loss was 1000 ml (500, 1000). The neonatal mortality rate was 18% (2/11) and 33% (3/9) of the survivors were discharged with a tracheostomy. EXIT is a reasonable option for delivery of babies with an occlusive upper airway mass. Neonatal survival depends on individualized factors but may be as high as 82% in those with teratoma.

Sections du résumé

BACKGROUND
Ex utero intrapartum treatment (EXIT) is utilized for safe delivery when a baby has a compromised airway. The purpose of this retrospective study was to examine the indications and outcomes of 11 children presenting with airway occluding oropharyngeal and cervical teratomas.
METHODS
Study of all children with an airway occluding teratoma delivered via EXIT (2001-2018) in our unit. Primary outcomes included survival and tracheostomy at discharge. Data are reported using descriptive statistics as median (range) and rate (%).
RESULTS
We performed 45 EXIT procedure performed between January 2001 and April 2018. Of these, eleven were for cervical and/or upper airway teratoma. Ten (91%) cases had associated polyhydramnios, two (18%) developed nonimmune hydrops, and eight (72%) delivered preterm. Six (45.5%) were performed as an emergency. Estimated blood loss was 1000 ml (500, 1000). The neonatal mortality rate was 18% (2/11) and 33% (3/9) of the survivors were discharged with a tracheostomy.
CONCLUSION
EXIT is a reasonable option for delivery of babies with an occlusive upper airway mass. Neonatal survival depends on individualized factors but may be as high as 82% in those with teratoma.

Identifiants

pubmed: 33386645
doi: 10.1002/pd.5894
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-504

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Shamshirsaz AA , Belfort MA , Ball R . Fetal surgery. In: Apuzzio JJ , Vintzileos AM , Iffy L , eds. Operative Obstetrics. 4th ed. Taylor & Francis; 2016:163-179.
Shamshirsaz AA , Ramine SM , Belfort MA . Fetal therapy. In: Gilstrep LC , ed. Operative Obstetrics. 3 ed. Appleton & Lange; 2016:260-175.
Dighe MK , Peterson SE , Dubinsky TJ , Perkins J , Cheng E . EXIT procedure: technique and indications with prenatal imaging parameters for assessment of airway patency. Radiographics. 2011;31(2):511-526.
Lazar DA , Cassady CI , Olutoye OO , et al. Tracheoesophageal displacement index and predictors of airway obstruction for fetuses with neck masses. J Pediatr Surg. 2012;47(1):46-50.
Azizkhan RG , Haase GM , Applebaum H , et al. Diagnosis, management, and outcome of cervicofacial teratomas in neonates: a Childrens Cancer Group study. J Pediatr Surg. 1995;30(2):312-316.
Olutoye OO , Olutoye OA . EXIT procedure for fetal neck masses. Curr Opin Pediatr. 2012;24(3):386-393.
Moldenhauer JS . Ex utero intrapartum therapy. Seminars Pediatr Surg. 2013;22(1):44-49.
Marwan A , Crombleholme TM . The EXIT procedure: principles, _pitfalls, and progress. Seminars Pediatr Surg. 2006;15(2):107-115.
Hamza A , Herr D , Solomayer EF , Meyberg-Solomayer G . Polyhydramnios: causes, diagnosis and therapy. Geburtshilfe Frauenheilkd. 2013;73(12):1241-1246.
Wilson RD , Hedrick H , Flake AW , et al. Sacrococcygeal teratomas: prenatal surveillance, growth and pregnancy outcome. Fetal diagnosis Ther. 2009;25(1):15-20.
Olutoye OO , Johnson MP , Coleman BG , Crombleholme TM , Adzick NS , Flake AW . Abnormal umbilical cord Doppler sonograms may predict impending demise in fetuses with sacrococcygeal teratoma. A report of two cases. Fetal diagnosis Ther. 2004;19(1):35-39.
Tongsong T , & Tatiyapornkul T . Cardiothoracic ratio in the first half of pregnancy. J Clin Ultrasound JCU. 2004;32(4):186-189.
Hedrick HL , Flake AW , Crombleholme TM , et al. The ex utero intrapartum therapy procedure for high-risk fetal lung lesions. J Pediatr Surg. 2005;40(6):1038-1043; discussion 44.
Shamshirsaz AA , Aalipour S , Erfani H , et al. Obstetric outcomes of ex-utero intrapartum treatment (EXIT). Prenat Diagn. 2019;39(8):643-646.
Shamshirsaz AA , Stewart KA , Erfani H , et al. Cervical lymphatic malformations: prenatal characteristics and ex utero intrapartum treatment. Prenat Diagn. 2019;39(4):287-292.
Laje P , Johnson MP , Howell LJ , et al. Ex utero intrapartum treatment in the management of giant cervical teratomas. J Pediatr Surg. 2012;47(6):1208-1216.
Erfani H , Diaz-Rodriguez GE , Aalipour S , et al. Amnioreduction in cases of polyhydramnios: indications and outcomes in singleton pregnancies without fetal interventions. Eur J Obstet Gynecol Reprod Biol. 2019;241:126-128.
Beckers K , Faes J , Deprest J , et al Long-term outcome of pre- and perinatal management of congenital head and neck tumors and malformations. Int J Pediatr Otorhinolaryngol. 2019 Jun;121:164-172.
Shamshirsaz AA , Nassr AA , Erfani H , et al. Fetoscopic laryngotracheoscopy: novel diagnostic modality to avoid unnecessary ex-utero intrapartum treatment (EXIT) in cases with suspected fetal airway compromise. Ultrasound Obstet Gynecol. 2019;53(3):421-423.

Auteurs

Alireza A Shamshirsaz (AA)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Soroush Aalipour (S)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Kelsey A Stewart (KA)

Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, Minnesota, USA.

Ahmed A Nassr (AA)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Department of Obstetrics and Gynecology, Women's Health Hospital, Assiut University, Egypt.

Betul Y Furtun (BY)

Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Hadi Erfani (H)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Nathan C Sundgren (NC)

Division of Neonatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Magdalena S Cortes (MS)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Roopali V Donepudi (RV)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Timothy C Lee (TC)

Division of Pediatric Surgery, Department of Surgery, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Deepak K Mehta (DK)

Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Elizabeth S Kravitz (ES)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Nazli M Asl (NM)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Jimmy Espinoza (J)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Michael A Belfort (MA)

Division of Fetal Therapy and Surgery, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH